Association of -308 TNF-α promoter polymorphism with clinical aggressiveness in patients with head and neck squamous cell carcinoma

Oral Oncology

Volumn 47, Issue 9, 2011, Pages 888-894

  Corrêa, Gefter Thiago Batista ^a   Bandeira, Gabriela Alencar ^a   Cavalcanti, Bruna Gonalves ^a   De Carvalho Fraga, Carlos Alberto ^a   Dos Santos, Erivelton Pereira ^a   Silva, Thiago Fonseca ^a   Gomez, Ricardo Santiago ^b   Guimarães, André Luiz Sena ^a   De Paula, Alfredo Maurício Batista ^a  

^a STATE UNIVERSITY OF MONTES CLAROS   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Clinicopathological factors; Head and neck; Polymorphism; Squamous cell carcinoma; Survival; TNF

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; CANCER PATIENT; FEMALE; GENE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SQUAMOUS CELL CARCINOMA; TNF ALPHA GENE; TUMOR VOLUME;

EID: 80052271503     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2011.07.001     Document Type: Article

References (71)

1. J.S. Cooper, K. Porter, K. Mallin, H.T. Hoffman, R.S. Weber, and K.K. Ang National cancer database report on cancer of the head and neck: 10-year update Head Neck 31 6 2009 748 758
2. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 5 2010 277 300
3. K. Manikantan, S. Khode, R.C. Dwivedi, R. Palav, C.M. Nutting, and P. Rhys-Evans Making sense of post-treatment surveillance in head and neck cancer: when and what of follow-up Cancer Treat Rev 35 8 2009 744 753
4. D.M. Parkin Global cancer statistics in the year 2000 Lancet Oncol 2 9 2001 533 543 (Pubitemid 33586866)
5. M.P. van der Schroeff, and R.J. Baatenburg de Jong Staging and prognosis in head and neck cancer Oral Oncol 45 4-5 2009 356 360
6. S. Warnakulasuriya Global epidemiology of oral and oropharyngeal cancer Oral Oncol 45 4-5 2009 309 316
7. S. Warnakulasuriya Significant oral cancer risk associated with low socioeconomic status Evid Based Dent 10 1 2009 4 5
8. A. Argiris, and C. Eng Epidemiology, staging, and screening of head and neck cancer Cancer Treat Res 114 2003 1560
9. G. D'Souza, A.R. Kreimer, R. Viscidi, M. Pawlita, C. Fakhry, and W.M. Koch Case-control study of human papillomavirus and oropharyngeal cancer N Engl J Med 356 19 2007 1944 1956 (Pubitemid 46740304)
10. A.M. De Paula, L.R. Souza, L.C. Farias, G.T. Correa, C.A. Fraga, and N.B. Eleuterio Analysis of 724 cases of primary head and neck squamous cell carcinoma (HNSCC) with a focus on young patients and p53 immunolocalization Oral Oncol 45 9 2009 777 782
11. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 6917 2002 860 867 (Pubitemid 36019639)
12. G. Dranoff Cytokines in cancer pathogenesis and cancer therapy Nat Rev Cancer 4 1 2004 11 22 (Pubitemid 38111131)
13. F. Balkwill Cancer and the chemokine network Nat Rev Cancer 4 7 2004 540 550 (Pubitemid 38868623)
14. R.M. Locksley, N. Killeen, and M.J. Lenardo The TNF and TNF receptor superfamilies: integrating mammalian biology Cell 104 4 2001 487 501 (Pubitemid 32201945)
15. F. Bazzoni, and B. Beutler The tumor necrosis factor ligand and receptor families N Engl J Med 334 26 1996 1717 1725 (Pubitemid 26193625)
16. B.A. Beutler The role of tumor necrosis factor in health and disease J Rheumatol Suppl 57 1999 16 21 (Pubitemid 29210245)
17. F.J. Lejeune, C. Ruegg, and D. Lienard Clinical applications of TNF-alpha in cancer Curr Opin Immunol 10 5 1998 573 580
18. F. Balkwill The molecular and cellular biology of the chemokines J Viral Hepat 5 1 1998 1 14 (Pubitemid 28370804)
19. F. Balkwill Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev 13 2 2002 135 141 (Pubitemid 34229388)
20. H. Fujiki, and T. Sugimura New classes of tumor promoters: teleocidin, aplysiatoxin, and palytoxin Adv Cancer Res 49 1987 223 264
21. C.H. Arnott, K.A. Scott, R.J. Moore, A. Hewer, D.H. Phillips, and P. Parker Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway Oncogene 21 31 2002 4728 4738 (Pubitemid 34879448)
22. K.M. Kroeger, K.S. Carville, and L.J. Abraham The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription Mol Immunol 34 5 1997 391 399 (Pubitemid 27368335)
23. A.G. Wilson, J.A. Symons, T.L. McDowell, H.O. McDevitt, and G.W. Duff Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation Proc Natl Acad Sci USA 94 7 1997 3195 3199 (Pubitemid 27157287)
24. D. Ahirwar, P. Kesarwani, P.K. Manchanda, A. Mandhani, and R.D. Mittal Anti- and proinflammatory cytokine gene polymorphism and genetic predisposition: association with smoking, tumor stage and grade, and bacillus Calmette-Guerin immunotherapy in bladder cancer Cancer Genet Cytogenet 184 1 2008 1 8 (Pubitemid 351814965)
25. I. Duarte, A. Santos, H. Sousa, R. Catarino, D. Pinto, and A. Matos G-308A TNF-alpha polymorphism is associated with an increased risk of invasive cervical cancer Biochem Biophys Res Commun 334 2 2005 588 592 (Pubitemid 40982407)
26. S. Mestiri, N. Bouaouina, A.S. Ben, and L. Chouchane A functional polymorphism of the tumor necrosis factor receptor-II gene associated with the survival and relapse prediction of breast carcinoma Cytokine 30 4 2005 182 187 (Pubitemid 40615966)
27. C.M. Shih, Y.L. Lee, H.L. Chiou, W. Chen, G.C. Chang, and M.C. Chou Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer Lung Cancer 52 1 2006 15 20 (Pubitemid 43340194)
28. R. Gupta, S.C. Sharma, and S.N. Das Association of TNF-alpha and TNFR1 promoters and 3′ UTR region of TNFR2 gene polymorphisms with genetic susceptibility to tobacco-related oral carcinoma in Asian Indians Oral Oncol 44 5 2008 455 463
29. C.J. Liu, Y.K. Wong, K.W. Chang, H.C. Chang, H.F. Liu, and Y.J. Lee Tumor necrosis factor-alpha promoter polymorphism is associated with susceptibility to oral squamous cell carcinoma J Oral Pathol Med 34 10 2005 608 612
30. Z. Serefoglou, C. Yapijakis, E. Nkenke, and E. Vairaktaris Genetic association of cytokine DNA polymorphisms with head and neck cancer Oral Oncol 44 12 2008 1093 1099
31. C. Yapijakis, Z. Serefoglou, A. Vylliotis, E. Nkenke, S. Derka, and S. Vassiliou Association of polymorphisms in tumor necrosis factor alpha and beta genes with increased risk for oral cancer Anticancer Res 29 6 2009 2379 2386
32. L.H. Sobin TNM: evolution and relation to other prognostic factors Semin Surg Oncol 21 1 2003 3 7 (Pubitemid 37127467)
33. J.J. Pindborg, P.A. Reichart, and C.J. Smith International typing of cancer and precancer of the oral mucosa 2 ed. 1997 Springer-Verlag Berlin
34. M.M. Oken, R.H. Creech, D.C. Tormey, J. Horton, T.E. Davis, and E.T. McFadden Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 6 1982 649 655 (Pubitemid 13149996)
35. C.G. Zubrod Cancer-appraisal of methods for the study of chemotherapy of cancer in man: thiophosphamide J Chronic Dis 1960 7 33
36. F. Roila, M. Lupattelli, M. Sassi, C. Basurto, S. Bracarda, and M. Picciafuoco Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scales Ann Oncol 2 6 1991 437 439
37. J.B. Sorensen, M. Klee, T. Palshof, and H.H. Hansen Performance status assessment in cancer patients. An inter-observer variability study Br J Cancer 67 4 1993 773 775 (Pubitemid 23101557)
38. A.L. Guimaraes, J.F. Correia-Silva, A.R. Sa, J.M. Victoria, M.G. Diniz, and F.O. Costa Investigation of functional gene polymorphisms IL-1beta, IL-6, IL-10, and TNF-alpha in individuals with recurrent aphthous stomatitis Arch Oral Biol 52 3 2007 268 272 (Pubitemid 46110825)
39. V. Wunsch-Filho, J. Eluf-Neto, P.A. Lotufo, W.A. Silva Jr. , and M.A. Zago Epidemiological studies in the information and genomics era: experience of the Clinical Genome of Cancer Project in Sao Paulo, Brazil Braz J Med Biol Res 39 4 2006 545 553
40. L. Tiret Gene-environment interaction: a central concept in multifactorial diseases Proc Nutr Soc 61 4 2002 457 463 (Pubitemid 36069934)
41. H. Fujiki, M. Suganuma, A. Komori, J. Yatsunami, S. Okabe, and T. Ohta A new tumor promotion pathway and its inhibitors Cancer Detect Prev 18 1 1994 1 7 (Pubitemid 2047285)
42. S. Mocellin, C.R. Rossi, P. Pilati, and D. Nitti Tumor necrosis factor, cancer, and anticancer therapy Cytokine Growth Factor Rev 16 1 2005 35 53 (Pubitemid 40279116)
43. F. Balkwill, and A. Mantovani Inflammation and cancer: back to Virchow? Lancet 357 9255 2001 539 545 (Pubitemid 32173595)
44. S. Yoshida, M. Ono, T. Shono, H. Izumi, T. Ishibashi, and H. Suzuki Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis Mol Cell Biol 17 7 1997 4015 4023 (Pubitemid 27281877)
45. Y. Zhang, S. Wang, Y. Li, Z. Xiao, Z. Hu, and J. Zhang Sophocarpine and matrine inhibit the production of TNF-alpha and IL-6 in murine macrophages and prevent cachexia-related symptoms induced by colon26 adenocarcinoma in mice Int Immunopharmacol 8 13-14 2008 1767 1772
46. Y.Y. Wang, G.H. Lo, K.H. Lai, J.S. Cheng, C.K. Lin, and P.I. Hsu Increased serum concentrations of tumor necrosis factor-alpha are associated with disease progression and malnutrition in hepatocellular carcinoma J Chin Med Assoc 66 10 2003 593 598
47. J. Nakashima, M. Tachibana, M. Ueno, A. Miyajima, S. Baba, and M. Murai Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer Clin Cancer Res 4 7 1998 1743 1748 (Pubitemid 28304737)
48. M. Krzystek-Korpacka, M. Matusiewicz, D. Diakowska, K. Grabowski, K. Blachut, and I. Kustrzeba-Wojcicka Impact of weight loss on circulating IL-1, IL-6, IL-8, TNF-alpha, VEGF-A, VEGF-C, and midkine in gastroesophageal cancer patients Clin Biochem 40 18 2007 1353 1360 (Pubitemid 350151421)
49. M. Correia, M. Cravo, P. Marques-Vidal, R. Grimble, A. Dias-Pereira, and S. Faias Serum concentrations of TNF-alpha as a surrogate marker for malnutrition and worse quality of life in patients with gastric cancer Clin Nutr 26 6 2007 728 735 (Pubitemid 350082498)
50. W.P. Cawthorn, and J.K. Sethi TNF-alpha and adipocyte biology FEBS Lett 582 1 2008 117 131
51. A. Lelbach, G. Muzes, and J. Feher Current perspectives of catabolic mediators of cancer cachexia Med Sci Monit 13 9 2007 RA168 RA173
52. A. Theologides Cancer cachexia Cancer 43 5 Suppl. 1979 2004 2012 (Pubitemid 9200535)
53. J.M. Argiles, S. Busquets, C. Garcia-Martinez, and F.J. Lopez-Soriano Mediators involved in the cancer anorexia-cachexia syndrome: past, present, and future Nutrition 21 9 2005 977 985 (Pubitemid 41188098)
54. M.J. Tisdale Cachexia in cancer patients Nat Rev Cancer 2 11 2002 862 871 (Pubitemid 37328904)
55. M. Buck, and M. Chojkier Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants EMBO J 15 8 1996 1753 1765 (Pubitemid 26119211)
56. P. Costelli, N. Carbo, L. Tessitore, G.J. Bagby, F.J. Lopez-Soriano, and J.M. Argiles Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model J Clin Invest 92 6 1993 2783 2789
57. M. Llovera, F.J. Lopez-Soriano, and J.M. Argiles Effects of tumor necrosis factor-alpha on muscle-protein turnover in female Wistar rats J Natl Cancer Inst 85 16 1993 1334 1339 (Pubitemid 23249726)
58. M. Llovera, F.J. Lopez-Soriano, and J.M. Argiles Chronic tumour necrosis factor-alpha treatment modifies protein turnover in rat tissues Biochem Mol Biol Int 30 1 1993 29 36 (Pubitemid 23199772)
59. M. Llovera, C. Garcia-Martinez, N. Agell, M. Marzabal, F.J. Lopez-Soriano, and J.M. Argiles Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats FEBS Lett 338 3 1994 311 318 (Pubitemid 24056743)
60. A.R. Kreimer, G.M. Clifford, P. Boyle, and S. Franceschi Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review Cancer Epidemiol Biomarkers Prev 14 2 2005 467 475 (Pubitemid 40270113)
61. G. Almadori, G. Cadoni, P. Cattani, P. Posteraro, E. Scarano, and F. Ottaviani Detection of human papillomavirus DNA in laryngeal squamous cell carcinoma by polymerase chain reaction Eur J Cancer 32A 5 1996 783 788
62. M.L. Gillison Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers J Clin Oncol 24 36 2006 5623 5625 (Pubitemid 46631299)
63. V.G. Gorgoulis, P. Zacharatos, A. Kotsinas, A. Kyroudi, A.N. Rassidakis, and J.A. Ikonomopoulos Human papilloma virus (HPV) is possibly involved in laryngeal but not in lung carcinogenesis Hum Pathol 30 3 1999 274 283 (Pubitemid 29125146)
64. S.M. Schwartz, J.R. Daling, D.R. Doody, G.C. Wipf, J.J. Carter, and M.M. Madeleine Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection J Natl Cancer Inst 90 21 1998 1626 1636 (Pubitemid 28523437)
65. S. Syrjanen Human papillomaviruses in head and neck carcinomas N Engl J Med 356 19 2007 1993 1995 (Pubitemid 46740312)
66. C.D. Woodworth, E. McMullin, M. Iglesias, and G.D. Plowman Interleukin 1 alpha and tumor necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells Proc Natl Acad Sci USA 92 7 1995 2840 2844
67. J.C. Machado, C. Figueiredo, P. Canedo, P. Pharoah, R. Carvalho, and S. Nabais A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma Gastroenterology 125 2 2003 364 371 (Pubitemid 36929416)
68. K. Nakajima, M. Sasaki, D. Nojima, B.R. Oh, N. Ishii, and K. Miura Tumor necrosis factor-alpha gene mutations and genotype changes in renal cell carcinoma J Urol 165 2 2001 612 615 (Pubitemid 32060488)
69. B.R. Oh, M. Sasaki, G. Perinchery, S.B. Ryu, Y.I. Park, and P. Carroll Frequent genotype changes at -308, and 488 regions of the tumor necrosis factor-alpha (TNF-alpha) gene in patients with prostate cancer J Urol 163 5 2000 1584 1587 (Pubitemid 30226331)
70. K. Warzocha, P. Ribeiro, J. Bienvenu, P. Roy, C. Charlot, and D. Rigal Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome Blood 91 10 1998 3574 3581 (Pubitemid 28225722)
71. J. Nowak, E. Kalinka-Warzocha, P. Juszczynski, P. Bilinski, R. Mika-Witkowska, and M. Zajko Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma Genes Chromosomes Cancer 46 5 2007 500 507 (Pubitemid 46449253)